An exploratory study on the application of interactive patient education in the treatment of primary frozen shoulder with hydrodilatation combined with hormone injection

Interactive patient education significantly improves the clinical efficacy of hydrodilatation combined with hormone injections in the idiopathic frozen shoulder treatment: a randomized controlled study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068347

Enrollment

Unknown

Registered

2023-02-15

Start date

2023-02-16

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

IPE group:interactive patient education

TPE group:traditional patient education

Eligibility

Sex/Gender

All

Age

23 Years to 71 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria Shoulder pain for at least one month Sleep disturbance: pain at night or inability to lie on the affected side Restriction of all active and passive glenohumeral range of motion Passive glenohumeral external rotation limitation of at least 50% compared to the healthy side Age: 18 to 70 years Male or female Using Wechat Those who signed informed consent and received follow-up

Exclusion criteria

Exclusion criteria: Exclusion criteria Resting pain Previously treated with water swelling of the shoulder cavity or hormone injections Hormone medication Shoulder osteoarthritis Systemic inflammatory disease Calcific tendinopathy Rotator cuff injury Local anesthetic allergy Pregnant Those who are unable to complete the follow-up Those with traumatic shoulder injury within six months Patients with neuropathic pain

Design outcomes

Primary

Measure	Time frame
VAS pain level;	—

Secondary

Measure	Time frame
ASES;FUSS;	—

Countries

China

Contacts

Public ContactTianwu Chen

Department of Sports Medicine, Huashan Hospital, Fudan University

13916762103@163.com+8613916762103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026